BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37646306)

  • 21. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
    Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular diagnosis angioimmunoblastic T-cell lymphoma].
    Chernova NG; Sidorova YV; Smirnova SY; Ryzhikova NV; Nikulina EE; Kovrigina AM; Sinitsyna MN; Sudarikov AB
    Ter Arkh; 2019 Jul; 91(7):63-69. PubMed ID: 32598737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
    Dupuy A; Lemonnier F; Fataccioli V; Martin-Garcia N; Robe C; Pelletier R; Poullot E; Moktefi A; Mokhtari K; Rousselet MC; Traverse-Glehen A; Delarue R; Tournilhac O; Delfau-Larue MH; Haioun C; Ortonne N; Copie-Bergman C; de Leval L; Pujals A; Gaulard P
    J Mol Diagn; 2018 Sep; 20(5):677-685. PubMed ID: 29981867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
    Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
    Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
    Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
    Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion.
    Tsuboi Y; Iimura Y; Matsumura F; Nanmoku T; Suma S; Matsuoka R; Nakagawa T; Nakagawa D; Suehara Y; Hattori K; Sato K; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Ieda M; Chiba S; Sakata-Yanagimoto M
    Intern Med; 2023 Feb; 62(4):595-600. PubMed ID: 35732446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
    Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in understanding of angioimmunoblastic T-cell lymphoma.
    Chiba S; Sakata-Yanagimoto M
    Leukemia; 2020 Oct; 34(10):2592-2606. PubMed ID: 32704161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL).
    Pritchett JC; Yang ZZ; Kim HJ; Villasboas JC; Tang X; Jalali S; Cerhan JR; Feldman AL; Ansell SM
    Leukemia; 2022 Jan; 36(1):165-176. PubMed ID: 34230608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT3A
    Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
    Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.
    Attygalle AD; Chuang SS; Diss TC; Du MQ; Isaacson PG; Dogan A
    Histopathology; 2007 Mar; 50(4):498-508. PubMed ID: 17448026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
    Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
    Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
    Tari G; Lemonnier F; Morschhauser F
    Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T-cell lymphoma.
    Wei C; Wang W; Zhang Y; Zhao D; Zhang W; Zhou D
    Br J Haematol; 2023 Jul; 202(1):86-95. PubMed ID: 37132364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
    Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
    Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.